King's top two drugs are Altace, a treatment for high blood pressure and the muscle relaxer Skelaxin. The company's shares rose 2.42 percent, or 25 cents, ...
King's top two drugs are Altace, a treatment for high blood pressure and the muscle relaxer Skelaxin. The company's shares rose 2.42 percent, or 25 cents, ...
Deputies spoke with Gower and found a prescription for Vicodin and Skelaxin, both prescription painkillers, from Physicians Regional Medical Center — Pine ...
Deputies spoke with Gower and found a prescription for Vicodin and Skelaxin, both prescription painkillers, from Physicians Regional Medical Center — Pine ...
King is also facing challenges to its patent for the muscle relaxant Skelaxin and greater generic competition for its hemostatic product, Thrombin-JMI. ...
Skelaxin sales were $106 million, flat with the year ago period. However, sales of Thrombin-Jmi, Sonata, and Levoxyl declined during the quarter. ...
Altace sales rose 6 percent to $169 million, while sales of the muscle relaxer Skelaxin were flat at $106 million. A US federal appeals court in September ...
Net sales of SKELAXIN(R) (metaxalone) totaled $106 million during each of the third quarters of 2007 and 2006. THROMBIN-JMI(R) (thrombin, topical, bovine, ...
... 30 September 30 2006 2007 2006 2007 US$m US$m US$m US$m ——————— ———————————————————- ———————- 13.3 15.1 Tricor(R) 36.0 42.2 10.3 10.6 Skelaxin(R) 24.7 ...
In recent years, King has developed a strong pain management franchise, which includes existing products like SKELAXIN ® (metaxalone) and AVINZA ® (morphine ...